FDA Inspection 1113855 — Hikma Pharmaceuticals USA INC.

Hikma Pharmaceuticals USA INC. — FEI 1510690

The FDA completed an inspection of Hikma Pharmaceuticals USA INC. on Nov 22, 2019 in Columbus, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Nov 22, 2019
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Columbus, OH (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.